Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v5-EN
Language English English
Date Updated 2020-03-14 2020-03-13
Drug Identification Number 02446375 02446375
Brand name AURO-SOLIFENACIN AURO-SOLIFENACIN
Common or Proper name Solifenacin succinate Solifenacin succinate
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients SOLIFENACIN SUCCINATE SOLIFENACIN SUCCINATE
Strength(s) 5MG 5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 30 & 100 30 & 100
ATC code G04BD G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-12-04 2019-12-04
Estimated end date
Actual end date 2020-03-13 2020-03-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments